Company says new data shows healthy 5 to 11-year-olds could benefit from another kid-sized shot; US has yet to allow vaccinations for children under 5

Sheba Medical Center will administer 200 doses of a new shot designed to have increased effectiveness against the variant as part of new research

Tel Aviv-based startup uses machine learning to build computational models of human diseases to speed up treatment discoveries

Chief Executive Albert Bourla says 2021 was a 'watershed year' for drugmaker, with its efforts during the pandemic 'fundamentally changed our company forever'

Request means young American children could begin to receive the shots in March; toddlers and preschoolers are only group still not eligible for vaccination against coronavirus

Regulators urging drugmaker to apply for emergency authorization of 2-dose regimen of shot for kids aged 6 months to 5 years old while awaiting data on 3-dose course

CEO Albert Bourla has said pharmaceutical giant could be ready to file for regulatory approval of tweaked dose by March

Albert Bourla says US-based pharma firm is aiming to produce annual shot to cover all COVID variants; accuses anti-vaxxers of causing millions of deaths by spreading misinformation

Prof. Shmuel Shapira, former head of the Defense Ministry’s Biological Institute, calls pharma giant's vaccines 'mediocre,' says company only wanted to 'rake in billions'

Bourla says boosters against coronavirus will remain necessary, but anti-COVID pill 'changes everything'